Session Details
[S49]The 9th current status of reverse translational research conducted by hospital pharmacists - Diversity of Pharmacist-scientist -
Sat. Mar 29, 2025 3:15 PM - 4:45 PM JST
Sat. Mar 29, 2025 6:15 AM - 7:45 AM UTC
Sat. Mar 29, 2025 6:15 AM - 7:45 AM UTC
Room 15 (MARINE MESSE FUKUOKA Hall B: Conference Room1-1 [2F])
Organizer: Satohiro Masuda (Dept. of Clin. Pharm., Himeji Dokkyo Univ.), Hiroki Itoh (Oita Univ. Hosp. Dept. Pharmacy), Ryuji Ikeda (Univ. Miyazaki Hosp. Dept. Pharmacy), Hirofumi Jono (Kumamoto Univ. Hosp. Dept. Pharmacy)
Recently, based on innovative advancements in pharmacotherapy, a variety of therapeutic drugs have recently been discovered. Although novel treatment agents that modulate the function of target molecules have been widely used in clinical settings, multiple trials and errors are often necessary due to a lack of enough clinical evidence, especially in new innovative pharmacotherapies. Therefore, clinical pharmacists are required to provide novel clinical evidence for more proper medication in medical settings.
In this symposium, we would like to present the latest topics and their backgrounds concerning the basic and clinical research conducted by "pharmacist-scientist" working in clinical, and discuss the current status of research conducted by hospital pharmacists, their issues, and future prospects, for discussing the meaning and importance of research activities in clinical settings.
In this symposium, we would like to present the latest topics and their backgrounds concerning the basic and clinical research conducted by "pharmacist-scientist" working in clinical, and discuss the current status of research conducted by hospital pharmacists, their issues, and future prospects, for discussing the meaning and importance of research activities in clinical settings.
オーガナイザー挨拶:増田 智先(姫路獨協大薬)
[S49-1]Dose optimization in special populations leveraging PMx
○Ryota Tanaka1 (1. Department of Clinical Pharmacy, Oita University Hospital)
[S49-2]Renoprotection and Multi-organ crosstalk by Suppressing Indoxyl Sulfate Production and Accumulation
○Yuki Narita1,2, Hirofumi Jono1,2, Hideyuki Saito1,2 (1. Department of Pharmacy, Kumamoto University Hospital, 2. Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University)
[S49-3]Therapeutic strategies for psychotropics utilizing blood drug concentrations: a practical approach by pharmacists
○Yumiko Akamine1 (1. Akita University Hospital)
[S49-4]Digital innovation and data-driven research by hospital pharmacists
○Hirofumi Hamano1,2 (1. Department of Pharmacy, Okayama University Hospital, 2. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University)